💼 Torrent Pharma Makes Strategic Move to Acquire JB Chemicals Stake
In a significant move to strengthen its foothold in India’s pharmaceutical sector, Torrent Pharmaceuticals has announced that it will acquire a 46.39% stake in JB Chemicals & Pharmaceuticals Ltd for a massive ₹11,917 crore. This acquisition aligns with Torrent's strategy of expanding in chronic and specialty therapy segments and enhancing its market leadership.
🧾 Deal Highlights
Stake Acquired: 46.39% in JB Chemicals
Deal Value: ₹11,917 crore
Seller: Private equity firm KKR, which had acquired JB Chemicals in 2020
Buyer: Torrent Pharma, one of India’s leading pharma companies
Funding: Through internal accruals and debt financing
🏭 What This Means for Torrent Pharma
This is Torrent Pharma's largest-ever acquisition, enabling the company to:
Enhance its chronic segment offerings (including cardiac, anti-hypertensive, and gastrointestinal drugs)
Leverage JB Chemicals’ strong domestic and export base
Expand operations in key growth markets like Russia, South Africa, and the U.S.
Strengthen presence in branded generics
🌍 About JB Chemicals & Pharmaceuticals Ltd
Founded in 1976, JB Chemicals is known for popular brands like Metrogyl, Rantac, Cilacar, and Nikita. The company has a strong presence in both India and emerging markets, and it operates multiple manufacturing facilities approved by global regulatory agencies.
📈 KKR’s Exit and Return on Investment
Private equity firm KKR had acquired a controlling stake in JB Chemicals in 2020 for ₹3,100 crore. With this sale to Torrent for ₹11,917 crore, KKR is exiting with a significant return on investment, highlighting the value appreciation of JB Chemicals under its leadership.
❓ FAQs
Q1. How much stake is Torrent Pharma acquiring in JB Chemicals?
Torrent is buying a 46.39% stake in JB Chemicals from KKR.
Q2. What is the value of the deal?
The acquisition is valued at approximately ₹11,917 crore.
Q3. Why is this deal significant?
It is Torrent Pharma’s biggest acquisition ever, boosting its position in chronic therapy segments and branded generics.
Q4. Who currently owns JB Chemicals?
The majority stake was held by KKR, which is now exiting the company.
Q5. How will the acquisition be financed?
Torrent plans to finance the deal using a mix of internal accruals and debt.
published on 30 june
Publisher : SMITA
www.vizzve.com || www.vizzveservices.com
Follow us on social media: Facebook || Linkedin || Instagram
🛡 Powered by Vizzve Financial
RBI-Registered Loan Partner | 10 Lakh+ Customers | ₹600 Cr+ Disbursed